MaxLinear, Inc.
MaxLinear, Inc. (MXL) Financial Performance & Income Statement Overview
Analyze MaxLinear, Inc. (MXL) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
MaxLinear, Inc. (MXL) Income Statement & Financial Overview
Access detailed annual and quarterly income data for MaxLinear, Inc. MXL financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $95.93M | $92.17M | $81.10M | $91.99M |
| Cost of Revenue | $42.10M | $40.92M | $37.02M | $42.40M |
| Gross Profit | $53.83M | $51.25M | $44.08M | $49.59M |
| Gross Profit Ratio | $0.56 | $0.56 | $0.54 | $0.54 |
| R&D Expenses | $55.46M | $51.28M | $52.60M | $56.54M |
| SG&A Expenses | $36.59M | $38.09M | $30.15M | $33.008M |
| Operating Expenses | $99.92M | $92.42M | $82.76M | $89.55M |
| Total Costs & Expenses | $134.15M | $133.34M | $119.78M | $131.94M |
| Interest Income | $864000.00 | $1.04M | $1.65M | $1.87M |
| Interest Expense | $2.50M | $2.80M | $2.65M | $2.71M |
| Depreciation & Amortization | $404000.00 | $11.71M | $10.14M | $11.63M |
| EBITDA | -$46.09M | -$26.31M | -$67.70M | -$26.99M |
| EBITDA Ratio | -$0.48 | -$0.29 | -$0.83 | -$0.29 |
| Operating Income | -$46.09M | -$41.17M | -$66.74M | -$39.95M |
| Operating Income Ratio | -$0.48 | -$0.45 | -$0.82 | -$0.43 |
| Other Income/Expenses (Net) | -$2.91M | $351000.00 | -$15.76M | -$1.37M |
| Income Before Tax | -$49.002M | -$40.82M | -$82.50M | -$41.33M |
| Income Before Tax Ratio | -$0.51 | -$0.44 | -$1.02 | -$0.45 |
| Income Tax Expense | $711000.00 | $17.02M | -$6.71M | -$2.06M |
| Net Income | -$49.71M | -$57.84M | -$75.78M | -$39.27M |
| Net Income Ratio | -$0.52 | -$0.63 | -$0.93 | -$0.43 |
| EPS | -$0.58 | -$0.68 | -$0.90 | -$0.47 |
| Diluted EPS | -$0.58 | -$0.68 | -$0.90 | -$0.47 |
| Weighted Avg Shares Outstanding | $85.27M | $84.48M | $84.07M | $83.48M |
| Weighted Avg Shares Outstanding (Diluted) | $85.27M | $84.48M | $84.07M | $83.48M |
Financial performance has remained strong, with revenue growing from $91.99M in Q2 2024 to $95.93M in Q1 2025. Gross profit continued to perform well, with margins at 56% in the latest quarter. Operating income reached -$46.09M in Q1 2025, holding a steady -48% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at -$46.09M. Net income rose to -$49.71M, keeping EPS at -$0.58. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan